Review



prostate epithelial cell line rwpe1  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC prostate epithelial cell line rwpe1
    Prostate Epithelial Cell Line Rwpe1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 714 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/RWPE-1/pm41454362-60-10-29
    Average 99 stars, based on 714 article reviews
    prostate epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Larvicidal and Cytotoxic Activities of Exopolysaccharides Produced by Thermophilic Bacteria
    Article Snippet: .. Cell culture Human prostate cancer cell line (PC-3) (CRL-1435, ATCC) and the normal prostate epithelial cell line (RWPE1) (CRL-11609, ATCC) were kindly provided by Prof. Dr. Sarhan Sakarya. ..

    Article Title: A Modified Coupled Spectrophotometric Method to Detect 2-5 Oligoadenylate Synthetase Activity in Prostate Cell Lines
    Article Snippet: All the cell lines were purchased from ATCC. .. The normal prostate epithelial cell line RWPE1 (ATCC) was cultured in K-SFM (keratinocyte serum free medium) supplemented with BPE (Bovine pituitary extract) and EGF (Epidermal growth factor) as per the supplier’s recommendation. ..

    Article Title: The FOXP4-AS1/miR-3130-3p/SP4 feedback loop is associated with prostate cancer.
    Article Snippet: .. Cell lines and cell culture Four human PCa cell lines (DU145, PC3, C4–2, LNCaP) and a normal prostate epithelial cell line (RWPE1) were obtained from ATCC (American Type Culture Collection; VA, USA). .. Cells were cultured in RPMI-1640 medium (Invitrogen; CA, USA) and added with 10% FBS (fetal bovine serum, Invitrogen), 100 U/mL penicillin, and 100 mg/mL streptomycin.



    Similar Products

    prostate epithelial cell line rwpe1  (ATCC)
    99
    ATCC prostate epithelial cell line rwpe1
    Prostate Epithelial Cell Line Rwpe1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/RWPE-1/pm41454362-60-10-29
    Average 99 stars, based on 1 article reviews
    prostate epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    human prostate epithelial cell line rwpe1  (ATCC)
    99
    ATCC human prostate epithelial cell line rwpe1
    Human Prostate Epithelial Cell Line Rwpe1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/RWPE-1/10__1620_slash_tjem__2025__j170-33-20-31
    Average 99 stars, based on 1 article reviews
    human prostate epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    non malignant prostate epithelial cell line rwpe1  (Procell Inc)
    86
    Procell Inc non malignant prostate epithelial cell line rwpe1
    CHD1L is significantly upregulated in prostate cancer. ( A ) CHD1L expression in all prostate cancer ( n = 497) and normal prostate tissues ( n = 52) from the TCGA-PCa cohort. ( B ) Paired comparison of CHD1L expression between prostate cancer ( n = 52) and matched adjacent normal tissues ( n = 52) from the TCGA-PRAD cohort. ( C ) CHD1L expression in prostate cancer ( n = 13) and normal prostate tissues ( n = 8) from the GSE55945 dataset. ( D ) CHD1L expression in prostate cancer ( n = 57) and normal prostate tissues ( n = 90) from the GSE72220 dataset. ( E ) CHD1L expression in AR-independent ( n = 10) vs. AR-dependent ( n = 10) prostate cancer in the GSE2443 dataset. ( F ) Immunohistochemical staining(antibody HPA027789) of CHD1L in prostate cancer tissues from the Protein Atlas database. ( G ) Kaplan-Meier survival analysis showing disease-free survival (DFS) based on CHD1L expression, performed by the GEPIA2 web tool ( http://gepia2.cancer-pku.cn ) based on TCGA-PCa data. ( H ) Correlation of CHD1L with MKI67, a proliferation marker. ( I - J ) CHD1L expression in prostate cancer cell lines (Lncap, 22RV1, PC3, DU145) and normal <t>RWPE1</t> cells. ( K - L ) CHD1L mRNA and protein levels in paired clinical prostate cancer specimens ( n = 6). ( M - N ) Five representative pairs and quantitative IHC scores from Tissue microarray (TMA)-based immunohistochemistry of paired prostate cancer ( n = 28) and adjacent normal samples ( n = 28). Error bars represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns, no significance; unpaired student’s t-test for 1 A, 1 C-1E; paired student’s t-test for 1B, 1 K and 1 N; one-way ANOVA for 1I
    Non Malignant Prostate Epithelial Cell Line Rwpe1, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/breast+cancer+cell+human+lines/pmc12781402-45-12-22
    Average 86 stars, based on 1 article reviews
    non malignant prostate epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    122 non malignant prostate epithelial cell line rwpe1  (Procell Inc)
    86
    Procell Inc 122 non malignant prostate epithelial cell line rwpe1
    CHD1L is significantly upregulated in prostate cancer. ( A ) CHD1L expression in all prostate cancer ( n = 497) and normal prostate tissues ( n = 52) from the TCGA-PCa cohort. ( B ) Paired comparison of CHD1L expression between prostate cancer ( n = 52) and matched adjacent normal tissues ( n = 52) from the TCGA-PRAD cohort. ( C ) CHD1L expression in prostate cancer ( n = 13) and normal prostate tissues ( n = 8) from the GSE55945 dataset. ( D ) CHD1L expression in prostate cancer ( n = 57) and normal prostate tissues ( n = 90) from the GSE72220 dataset. ( E ) CHD1L expression in AR-independent ( n = 10) vs. AR-dependent ( n = 10) prostate cancer in the GSE2443 dataset. ( F ) Immunohistochemical staining(antibody HPA027789) of CHD1L in prostate cancer tissues from the Protein Atlas database. ( G ) Kaplan-Meier survival analysis showing disease-free survival (DFS) based on CHD1L expression, performed by the GEPIA2 web tool ( http://gepia2.cancer-pku.cn ) based on TCGA-PCa data. ( H ) Correlation of CHD1L with MKI67, a proliferation marker. ( I - J ) CHD1L expression in prostate cancer cell lines (Lncap, 22RV1, PC3, DU145) and normal <t>RWPE1</t> cells. ( K - L ) CHD1L mRNA and protein levels in paired clinical prostate cancer specimens ( n = 6). ( M - N ) Five representative pairs and quantitative IHC scores from Tissue microarray (TMA)-based immunohistochemistry of paired prostate cancer ( n = 28) and adjacent normal samples ( n = 28). Error bars represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns, no significance; unpaired student’s t-test for 1 A, 1 C-1E; paired student’s t-test for 1B, 1 K and 1 N; one-way ANOVA for 1I
    122 Non Malignant Prostate Epithelial Cell Line Rwpe1, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/breast+cancer+cell+human+lines/pm41339923-59-12-23
    Average 86 stars, based on 1 article reviews
    122 non malignant prostate epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    human normal prostate epithelial cell line rwpe1  (ATCC)
    99
    ATCC human normal prostate epithelial cell line rwpe1
    CHD1L is significantly upregulated in prostate cancer. ( A ) CHD1L expression in all prostate cancer ( n = 497) and normal prostate tissues ( n = 52) from the TCGA-PCa cohort. ( B ) Paired comparison of CHD1L expression between prostate cancer ( n = 52) and matched adjacent normal tissues ( n = 52) from the TCGA-PRAD cohort. ( C ) CHD1L expression in prostate cancer ( n = 13) and normal prostate tissues ( n = 8) from the GSE55945 dataset. ( D ) CHD1L expression in prostate cancer ( n = 57) and normal prostate tissues ( n = 90) from the GSE72220 dataset. ( E ) CHD1L expression in AR-independent ( n = 10) vs. AR-dependent ( n = 10) prostate cancer in the GSE2443 dataset. ( F ) Immunohistochemical staining(antibody HPA027789) of CHD1L in prostate cancer tissues from the Protein Atlas database. ( G ) Kaplan-Meier survival analysis showing disease-free survival (DFS) based on CHD1L expression, performed by the GEPIA2 web tool ( http://gepia2.cancer-pku.cn ) based on TCGA-PCa data. ( H ) Correlation of CHD1L with MKI67, a proliferation marker. ( I - J ) CHD1L expression in prostate cancer cell lines (Lncap, 22RV1, PC3, DU145) and normal <t>RWPE1</t> cells. ( K - L ) CHD1L mRNA and protein levels in paired clinical prostate cancer specimens ( n = 6). ( M - N ) Five representative pairs and quantitative IHC scores from Tissue microarray (TMA)-based immunohistochemistry of paired prostate cancer ( n = 28) and adjacent normal samples ( n = 28). Error bars represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns, no significance; unpaired student’s t-test for 1 A, 1 C-1E; paired student’s t-test for 1B, 1 K and 1 N; one-way ANOVA for 1I
    Human Normal Prostate Epithelial Cell Line Rwpe1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/RWPE-1/pmc11779845-373-0-23
    Average 99 stars, based on 1 article reviews
    human normal prostate epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    prostate primary epithelial cell line rwpe1  (ATCC)
    99
    ATCC prostate primary epithelial cell line rwpe1
    Figure 8. Expression of AC087276.2, CNNM3‑DT, AC090198.1, AC138207.5, METTL14‑DT and LINC01515 in a normal prostate epithelial cell line <t>(RWPE1)</t> and prostate cancer cell lines (DU145 and PC3), as determined by reverse transcription‑quantitative PCR. ns, not significant; *P<0.05, ***P<0.001 ****P<0.0001.
    Prostate Primary Epithelial Cell Line Rwpe1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prostate+epithelial+cell+line+rwpe1/RWPE-1/pm39268161-85-2-20
    Average 99 stars, based on 1 article reviews
    prostate primary epithelial cell line rwpe1 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    CHD1L is significantly upregulated in prostate cancer. ( A ) CHD1L expression in all prostate cancer ( n = 497) and normal prostate tissues ( n = 52) from the TCGA-PCa cohort. ( B ) Paired comparison of CHD1L expression between prostate cancer ( n = 52) and matched adjacent normal tissues ( n = 52) from the TCGA-PRAD cohort. ( C ) CHD1L expression in prostate cancer ( n = 13) and normal prostate tissues ( n = 8) from the GSE55945 dataset. ( D ) CHD1L expression in prostate cancer ( n = 57) and normal prostate tissues ( n = 90) from the GSE72220 dataset. ( E ) CHD1L expression in AR-independent ( n = 10) vs. AR-dependent ( n = 10) prostate cancer in the GSE2443 dataset. ( F ) Immunohistochemical staining(antibody HPA027789) of CHD1L in prostate cancer tissues from the Protein Atlas database. ( G ) Kaplan-Meier survival analysis showing disease-free survival (DFS) based on CHD1L expression, performed by the GEPIA2 web tool ( http://gepia2.cancer-pku.cn ) based on TCGA-PCa data. ( H ) Correlation of CHD1L with MKI67, a proliferation marker. ( I - J ) CHD1L expression in prostate cancer cell lines (Lncap, 22RV1, PC3, DU145) and normal RWPE1 cells. ( K - L ) CHD1L mRNA and protein levels in paired clinical prostate cancer specimens ( n = 6). ( M - N ) Five representative pairs and quantitative IHC scores from Tissue microarray (TMA)-based immunohistochemistry of paired prostate cancer ( n = 28) and adjacent normal samples ( n = 28). Error bars represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns, no significance; unpaired student’s t-test for 1 A, 1 C-1E; paired student’s t-test for 1B, 1 K and 1 N; one-way ANOVA for 1I

    Journal: Journal of Translational Medicine

    Article Title: Targeting CHD1L suppresses prostate cancer progression via the FOXO3-PUMA axis

    doi: 10.1186/s12967-025-07529-5

    Figure Lengend Snippet: CHD1L is significantly upregulated in prostate cancer. ( A ) CHD1L expression in all prostate cancer ( n = 497) and normal prostate tissues ( n = 52) from the TCGA-PCa cohort. ( B ) Paired comparison of CHD1L expression between prostate cancer ( n = 52) and matched adjacent normal tissues ( n = 52) from the TCGA-PRAD cohort. ( C ) CHD1L expression in prostate cancer ( n = 13) and normal prostate tissues ( n = 8) from the GSE55945 dataset. ( D ) CHD1L expression in prostate cancer ( n = 57) and normal prostate tissues ( n = 90) from the GSE72220 dataset. ( E ) CHD1L expression in AR-independent ( n = 10) vs. AR-dependent ( n = 10) prostate cancer in the GSE2443 dataset. ( F ) Immunohistochemical staining(antibody HPA027789) of CHD1L in prostate cancer tissues from the Protein Atlas database. ( G ) Kaplan-Meier survival analysis showing disease-free survival (DFS) based on CHD1L expression, performed by the GEPIA2 web tool ( http://gepia2.cancer-pku.cn ) based on TCGA-PCa data. ( H ) Correlation of CHD1L with MKI67, a proliferation marker. ( I - J ) CHD1L expression in prostate cancer cell lines (Lncap, 22RV1, PC3, DU145) and normal RWPE1 cells. ( K - L ) CHD1L mRNA and protein levels in paired clinical prostate cancer specimens ( n = 6). ( M - N ) Five representative pairs and quantitative IHC scores from Tissue microarray (TMA)-based immunohistochemistry of paired prostate cancer ( n = 28) and adjacent normal samples ( n = 28). Error bars represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns, no significance; unpaired student’s t-test for 1 A, 1 C-1E; paired student’s t-test for 1B, 1 K and 1 N; one-way ANOVA for 1I

    Article Snippet: The prostate cancer cell lines DU145, PC3, 22RV1, LnCAP, RM1 and the non-malignant prostate epithelial cell line RWPE1 were all obtained from Procell Life Science & Technology.

    Techniques: Expressing, Comparison, Immunohistochemical staining, Staining, Marker, Microarray, Immunohistochemistry

    Figure 8. Expression of AC087276.2, CNNM3‑DT, AC090198.1, AC138207.5, METTL14‑DT and LINC01515 in a normal prostate epithelial cell line (RWPE1) and prostate cancer cell lines (DU145 and PC3), as determined by reverse transcription‑quantitative PCR. ns, not significant; *P<0.05, ***P<0.001 ****P<0.0001.

    Journal: Oncology letters

    Article Title: Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer.

    doi: 10.3892/ol.2024.14659

    Figure Lengend Snippet: Figure 8. Expression of AC087276.2, CNNM3‑DT, AC090198.1, AC138207.5, METTL14‑DT and LINC01515 in a normal prostate epithelial cell line (RWPE1) and prostate cancer cell lines (DU145 and PC3), as determined by reverse transcription‑quantitative PCR. ns, not significant; *P<0.05, ***P<0.001 ****P<0.0001.

    Article Snippet: The immortalized prostate primary epithelial cell line RWPE1, and the PCa cell lines PC3 and DU145 were obtained from the American Type Culture Collection.

    Techniques: Expressing